JRDG:LSE:LSE-JPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity UCITS ETF - USD (dist) GBX (GBX)

ETF | Others |

Last Closing

USD 3681.75

Change

0.00 (0.00)%

Market Cap

USD 0.44B

Volume

8.17K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+0.84 (+0.30%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+0.13 (+0.19%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.52 (-1.23%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.15 (+1.09%)

USD 608.02B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.24 (+1.39%)

USD 608.02B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+23.25 (+1.16%)

USD 321.87B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.47%)

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing JRDG:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.49% 84% B 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.49% 84% B 79% B-
Trailing 12 Months  
Capital Gain 21.79% 82% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.79% 81% B- 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.95% 60% D- 64% D
Dividend Return 6.95% 60% D- 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.05% 68% D+ 82% B
Risk Adjusted Return 76.76% 86% B+ 91% A-
Market Capitalization 0.44B 67% D+ 51% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike